Relationship between the effects of vortioxetine and sleep EEG findings in depression

Relationship between the effects of vortioxetine and sleep EEG findings in depression - Relationship between the effects of vortioxetine and sleep EEG findings in depression

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047036

Enrollment

Registered

2022-03-01

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Recording sleep EEG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subjects between the ages of 20 and 65 years at the time of consent 2) Subjects who provided informed consent by his/her free will with sufficient explanation and understanding for participation in the study 3) Subjects who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria for major depressive disorder 4) Subjects who are scheduled to receive vortioxetine

Exclusion criteria

Exclusion criteria: 1) Those who have received antidepressants within the past 4 weeks 2) Patients who have or have had any of the following disorders: - Schizophrenia or other psychotic disorders - Bipolar disorder - Dementia or other neurodegenerative diseases - Substance abuse including alcohol 3) Patients with severe physical illness 4) Pregnant or lactating women or those who wish to get pregnant during the observation period of the study 5) Others who are judged to be inappropriate by the principal investigator

Design outcomes

Primary

Measure	Time frame
Changes in sleep EEG during the course of treatment	—

Countries

Japan

Contacts

Public ContactMasahiro Suzuki

Nihon University Itabashi Hospital Psychiatry

suzuki.masahiro94@nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026